@melbournecitygirl's GHK-Cu claims need more context

What does this video actually claim?

The TikTok from @melbournecitygirl simply mentions "GHK-CU" without making specific health claims. With just those four characters and ellipsis, there's not much to fact-check directly.

But the video appears in the peptide therapy space, where GHK-Cu (glycyl-L-histidyl-L-lysine-copper) gets promoted for anti-aging, wound healing, and skin benefits. The minimalist approach might be intentional given regulatory scrutiny around peptide marketing.

Without explicit claims, we're left analyzing what's typically said about this copper-binding tripeptide in wellness circles.

Does the science actually support GHK-Cu benefits?

The research on GHK-Cu is limited but shows some promise in specific areas. Most studies focus on topical applications rather than injectable forms popular in peptide therapy.

Pickart et al. (2012) found GHK-Cu improved wound healing in diabetic mice. Human studies are scarce. A small 2012 study by Arul et al. showed faster wound closure with GHK-Cu cream in 20 patients, but this was topical use, not systemic injection.

For anti-aging claims, the evidence gets thinner. Some cell culture studies suggest GHK-Cu might stimulate collagen production, but translating petri dish results to real-world benefits is a big leap.

What's missing from the peptide therapy conversation?

The peptide therapy community often oversells GHK-Cu based on preliminary research. Injectable GHK-Cu hasn't been tested in large-scale human trials for anti-aging or systemic benefits.

Safety data is also limited. While topical copper peptides seem well-tolerated, injecting GHK-Cu regularly could theoretically cause copper accumulation. No long-term studies have tracked this risk.

The FDA doesn't regulate these peptides as drugs, creating a gray market where quality and dosing vary wildly between suppliers.

What should you actually know about GHK-Cu?

GHK-Cu might have legitimate benefits, but the current evidence doesn't justify the hype in peptide therapy circles. The promising wound healing research involved topical application, not injection.

If you're considering GHK-Cu, topical formulations have better safety profiles than injectable versions. The research supporting skin benefits, while limited, at least exists for this route of administration.

Don't expect dramatic anti-aging results based on current evidence. The studies showing benefits used small sample sizes and short timeframes. Larger, longer trials are needed before making strong claims about GHK-Cu's effects.